Subscribe to RSS
DOI: 10.1055/s-0043-1767821
Incidence of cardioembolic stroke related to atrial fibrillation in Joinville, Brazil
Incidência de acidente vascular encefálico relacionado à fibrilação atrial em Joinville, Brasil
Abstract
Background Atrial fibrillation (AF) is an important cause of cardioembolic stroke, and population aging has increased its prevalence.
Objective To evaluate the incidence of cardioembolic stroke caused by AF in the city of Joinville, Brazil, as well as previous diagnoses and use of medication.
Methods Between 2017 and 2020 we extracted data from the population-based Joinville Stroke Registry. Demographic characteristics, diagnosis of AF, and patterns of medication use were collected, and the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) system was used to classify the etiology.
Results There were 3,303 cases of ischemic stroke, 593 of which were cardioembolic, and 360 had AF. Of the patients with AF, 258 (71.6%) had a previous diagnosis of the disease, and 102 (28.3%) were newly diagnosed after the stroke. Among patients with a previously-diagnosed AF, 170 (47.2%) were using anticoagulants, and 88 (24.4%) were using other medications.
Conclusion During the analyzed period, ischemic stroke caused by AF was a significant burden on the population of Joinville, and a considerable number of patients had undiagnosed or untreated AF.
Resumo
Antecedentes A fibrilação atrial (FA) é uma importante causa de acidente vascular cebebral (AVC) cardioembólico, e o envelhecimento populacional aumentou a sua prevalência.
Objetivo Avaliar a incidência de AVC cardioembólico causado por FA em Joinville, além dos diagnósticos prévios e do uso de medicamentos.
Métodos Entre 2017 e 2020, foram extraídos dados do registro de base populacional de AVC de Joinville. Características demográficas, diagnóstico de FA e padrões de uso de medicamentos foram coletados, e o sistema Trial of ORG 10172 in Acute Stroke Treatment (TOAST) foi utilizado para classificar a etiologia.
Resultados Houve 3.303 casos de AVC isquêmico, sendo 593 cardioembólicos e 360 com FA. Dos pacientes com FA, 258 (71,6%) tinham diagnóstico prévio da doença, e 102 (28,3%) foram recém-diagnosticados após o AVC. Entre os pacientes com FA previamente diagnosticada, 170 (47,2%) estavam em uso de anticoagulante, e 88 (24,4%), em uso de outra medicação.
Conclusão Durante o período analisado, o AVC isquêmico causado por FA foi um ônus significativo para a população de Joinville, e um número considerável de pacientes apresentava FA não diagnosticada ou não tratada.
Authors' Contributions
All authors contributed to data collection, information organization, and article writing. All authors approved the final version.
Publication History
Received: 17 October 2022
Accepted: 16 December 2022
Article published online:
09 May 2023
© 2023. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution 4.0 International License, permitting copying and reproduction so long as the original work is given appropriate credit (https://creativecommons.org/licenses/by/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Kamel H, Healey JS. Cardioembolic Stroke. Circ Res 2017; 120 (03) 514-526 DOI: 10.1161/CIRCRESAHA.116.308407.
- 2 Cabral NL, Nagel V, Conforto AB. et al. High five-year mortality rates of ischemic stroke subtypes: A prospective cohort study in Brazil. Int J Stroke 2019; 14 (05) 491-499 DOI: 10.1177/1747493018806197.
- 3 Lin HJ, Wolf PA, Kelly-Hayes M. et al. Stroke severity in atrial fibrillation. The Framingham Study. Stroke 1996; 27 (10) 1760-1764 DOI: 10.1161/01.str.27.10.1760.
- 4 Engdahl J, Andersson L, Mirskaya M, Rosenqvist M. Stepwise screening of atrial fibrillation in a 75-year-old population: implications for stroke prevention. Circulation 2013; 127 (08) 930-937 DOI: 10.1161/CIRCULATIONAHA.112.126656.
- 5 Pistoia F, Sacco S, Tiseo C, Degan D, Ornello R, Carolei A. The Epidemiology of Atrial Fibrillation and Stroke. Cardiol Clin 2016; 34 (02) 255-268 DOI: 10.1016/j.ccl.2015.12.002.
- 6 Hayden DT, Hannon N, Callaly E. et al. Rates and Determinants of 5-Year Outcomes After Atrial Fibrillation-Related Stroke: A Population Study. Stroke 2015; 46 (12) 3488-3493 DOI: 10.1161/STROKEAHA.115.011139.
- 7 Joinville (SC) | Cidades e Estados | IBGE [Internet]. Ibge.gov.br. 2021. Available from: https://www.ibge.gov.br/cidades-e-estados/sc/joinville.html
- 8 Cabral NL, Gonçalves ARR, Longo AL. et al. Trends in stroke incidence, mortality and case fatality rates in Joinville, Brazil: 1995-2006. J Neurol Neurosurg Psychiatry 2009; 80 (07) 749-754 DOI: 10.1136/jnnp.2008.164475.
- 9 Feigin VL, Lawes CM, Bennett DA, Barker-Collo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009; 8 (04) 355-369 DOI: 10.1016/S1474-4422(09)70025-0.
- 10 Ferro JM. Cardioembolic stroke: an update. Lancet Neurol 2003; 2 (03) 177-188 DOI: 10.1016/s1474-4422(03)00324-7.
- 11 Adams Jr HP, Bendixen BH, Kappelle LJ. et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24 (01) 35-41 DOI: 10.1161/01.str.24.1.35.
- 12 Oliveira-Filho J, Martins SC, Pontes-Neto OM. et al; Executive Committee from Brazilian Stroke Society and the Scientific Department in Cerebrovascular Diseases. Guidelines for acute ischemic stroke treatment: part I. Arq Neuropsiquiatr 2012; 70 (08) 621-629 DOI: 10.1590/S0004-282X2012000800012.
- 13 Stroke Risk in Atrial Fibrillation Working Group. Independent predictors of stroke in patients with atrial fibrillation: a systematic review. Neurology 2007; 69 (06) 546-554 DOI: 10.1212/01.wnl.0000267275.68538.8d.
- 14 January CT, Wann LS, Calkins H. et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation 2019; 140 (02) e125-e151 DOI: 10.1161/CIR.0000000000000665.
- 15 Magalhaes L, Figueiredo MJO, Cintra FD. et al. II Diretrizes Brasileiras de Fibrilação atrial. Arq Bras Cardiol 2016; 106: 1-22
- 16 Ogilvie IM, Newton N, Welner SA, Cowell W, Lip GY. Underuse of oral anticoagulants in atrial fibrillation: a systematic review. Am J Med 2010; 123 (07) 638-645.e4 DOI: 10.1016/j.amjmed.2009.11.025.
- 17 Amaral CHD, Amaral AR, Nagel V. et al. Incidence and functional outcome of atrial fibrillation and non-atrial fibrillation- related cardioembolic stroke in Joinville, Brazil: a population-based study. Arq Neuropsiquiatr 2017; 75 (05) 288-294 DOI: 10.1590/0004-282X20170039.
- 18 Hajat C, Heuschmann PU, Coshall C. et al. Incidence of aetiological subtypes of stroke in a multi-ethnic population based study: the South London Stroke Register. J Neurol Neurosurg Psychiatry 2011; 82 (05) 527-533 DOI: 10.1136/jnnp.2010.222919.
- 19 O'Carroll CB, Barrett KM. Cardioembolic Stroke. Continuum (Minneap Minn) 2017; 23 (1, Cerebrovascular Disease): 111-132 DOI: 10.1212/CON.0000000000000419.
- 20 Rizos T, Wagner A, Jenetzky E. et al. Paroxysmal atrial fibrillation is more prevalent than persistent atrial fibrillation in acute stroke and transient ischemic attack patients. Cerebrovasc Dis 2011; 32 (03) 276-282 DOI: 10.1159/000330348.
- 21 Pujol Lereis VA, Ameriso S, Povedano GP, Ameriso SF. Ischemic stroke in patients with atrial fibrillation receiving oral anticoagulation. J Neurol Sci 2013; 334 (1-2): 139-142 DOI: 10.1016/j.jns.2013.08.013.
- 22 Sposato LA, Cipriano LE, Saposnik G, Ruíz Vargas E, Riccio PM, Hachinski V. Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. Lancet Neurol 2015; 14 (04) 377-387 DOI: 10.1016/S1474-4422(15)70027-X.